The global precision medicine market represents a massive, fast-growing sector valued in the tens of billions of dollars, with multi-billion-dollar compound annual growth projections driven by advancements in genomic sequencing, targeted oncology therapies, companion diagnostics, and personalized healthcare solutions. Major pharmaceutical investments and institutional buyouts continue to accelerate infrastructure scaling across this specialized medical ecosystem.